These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31230165)

  • 1. Detection and characterization of bacterial polysaccharides in drug-resistant enterococci.
    Ali L; Blum HE; Sakιnç T
    Glycoconj J; 2019 Oct; 36(5):429-438. PubMed ID: 31230165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.
    Kodali S; Vinogradov E; Lin F; Khoury N; Hao L; Pavliak V; Jones CH; Laverde D; Huebner J; Jansen KU; Anderson AS; Donald RG
    J Biol Chem; 2015 Aug; 290(32):19512-26. PubMed ID: 26109072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.
    Huebner J; Wang Y; Krueger WA; Madoff LC; Martirosian G; Boisot S; Goldmann DA; Kasper DL; Tzianabos AO; Pier GB
    Infect Immun; 1999 Mar; 67(3):1213-9. PubMed ID: 10024563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage.
    Romero-Saavedra F; Laverde D; Kalfopoulou E; Martini C; Torelli R; Martinez-Matamoros D; Sanguinetti M; Huebner J
    J Infect Dis; 2019 Oct; 220(10):1589-1598. PubMed ID: 31289829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.
    Theilacker C; Kaczyński Z; Kropec A; Sava I; Ye L; Bychowska A; Holst O; Huebner J
    PLoS One; 2011 Mar; 6(3):e17839. PubMed ID: 21437253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci.
    Kalfopoulou E; Laverde D; Miklic K; Romero-Saavedra F; Malic S; Carboni F; Adamo R; Lenac Rovis T; Jonjic S; Huebner J
    Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31285252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of the putative polysaccharide biosynthesis protein (CapD) of Enterococcus faecium U0317.
    Ali L; Spiess M; Wobser D; Rodriguez M; Blum HE; Sakιnç T
    Infect Genet Evol; 2016 Jan; 37():215-24. PubMed ID: 26611826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.
    Theilacker C; Kaczynski Z; Kropec A; Fabretti F; Sange T; Holst O; Huebner J
    Infect Immun; 2006 Oct; 74(10):5703-12. PubMed ID: 16988246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections.
    Romero-Saavedra F; Laverde D; Budin-Verneuil A; Muller C; Bernay B; Benachour A; Hartke A; Huebner J
    PLoS One; 2015; 10(8):e0136625. PubMed ID: 26322633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a capsular polysaccharide from Enterococcus faecium U0317 using a targeted approach to discover immunogenic carbohydrates for vaccine development.
    Laverde D; Armiento S; Molinaro A; Huebner J; De Castro C; Romero-Saavedra F
    Carbohydr Polym; 2024 Apr; 330():121731. PubMed ID: 38368077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
    Laverde D; Wobser D; Romero-Saavedra F; Hogendorf W; van der Marel G; Berthold M; Kropec A; Codee J; Huebner J
    PLoS One; 2014; 9(10):e110953. PubMed ID: 25333799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis.
    Hendrickx AP; van Schaik W; Willems RJ
    Future Microbiol; 2013 Aug; 8(8):993-1010. PubMed ID: 23902146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection.
    Sava IG; Heikens E; Kropec A; Theilacker C; Willems R; Huebner J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1001-1004. PubMed ID: 20522627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical characterization of polysaccharide antigens from six clinical strains of Enterococci.
    Hsu CT; Ganong AL; Reinap B; Mourelatos Z; Huebner J; Wang JY
    BMC Microbiol; 2006 Jul; 6():62. PubMed ID: 16836754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections.
    Kropec A; Sava IG; Vonend C; Sakinc T; Grohmann E; Huebner J
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3429-3434. PubMed ID: 21903755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enterococcal infections. Clinical findings and treatment considering antibiotic resistance in Denmark].
    Olesen HV; Møller JK
    Ugeskr Laeger; 2002 Apr; 164(18):2386-90. PubMed ID: 12024841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.
    Huebner J; Quaas A; Krueger WA; Goldmann DA; Pier GB
    Infect Immun; 2000 Aug; 68(8):4631-6. PubMed ID: 10899866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical structure of wall teichoic acid isolated from Enterococcus faecium strain U0317.
    Bychowska A; Theilacker C; Czerwicka M; Marszewska K; Huebner J; Holst O; Stepnowski P; Kaczyński Z
    Carbohydr Res; 2011 Dec; 346(17):2816-9. PubMed ID: 22024569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens.
    Sadones O; Kramarska E; Laverde D; Berisio R; Huebner J; Romero-Saavedra F
    BMC Microbiol; 2024 Jul; 24(1):280. PubMed ID: 39068414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.